Mirum Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MIRUM
MIRUM has four approved drugs.
There are ten US patents protecting MIRUM drugs.
Summary for Mirum
| US Patents: | 10 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 4 |
Drugs and US Patents for Mirum
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mirum | LIVMARLI | maralixibat chloride | TABLET;ORAL | 219485-004 | Apr 10, 2025 | RX | Yes | Yes | 12,296,050 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Mirum | LIVMARLI | maralixibat chloride | TABLET;ORAL | 219485-001 | Apr 10, 2025 | RX | Yes | No | 11,229,661 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mirum | LIVMARLI | maralixibat chloride | TABLET;ORAL | 219485-003 | Apr 10, 2025 | RX | Yes | No | 10,512,657 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mirum | LIVMARLI | maralixibat chloride | TABLET;ORAL | 219485-002 | Apr 10, 2025 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Mirum | CTEXLI | chenodiol | TABLET;ORAL | 219488-001 | Feb 21, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Mirum | LIVMARLI | maralixibat chloride | TABLET;ORAL | 219485-001 | Apr 10, 2025 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Mirum | LIVMARLI | maralixibat chloride | TABLET;ORAL | 219485-003 | Apr 10, 2025 | RX | Yes | No | 11,229,661 | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Mirum Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 7237544 | ⤷ Start Trial |
| Eurasian Patent Organization | 201490852 | ⤷ Start Trial |
| Singapore | 10201407013Q | ⤷ Start Trial |
| China | 104023718 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2013063526 | ⤷ Start Trial |
| Hong Kong | 1248117 | ⤷ Start Trial |
| Mexico | 2021009622 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Mirum Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2771003 | CA 2023 00017 | Denmark | ⤷ Start Trial | PRODUCT NAME: MARALIXIBAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, ISAER MARALIXIBATCHLORID; REG. NO/DATE: EU/1/22/1704 20221212 |
| 2771003 | 301234 | Netherlands | ⤷ Start Trial | PRODUCT NAME: MARALIXIBAT OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, IN HET BIJZONDER MARALIXIBATCHLORIDE; REGISTRATION NO/DATE: EU/1/22/1704 20221212 |
| 2771003 | 2390017-8 | Sweden | ⤷ Start Trial | PRODUCT NAME: MARALIXIBAT, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR MARALIXIBAT CHLORIDE; REG. NO/DATE: EU/1/22/1704 20221212 |
| 1392714 | CR 2017 00025 | Denmark | ⤷ Start Trial | PRODUCT NAME: OBETICHOLIC ACID; REG. NO/DATE: EU/1/16/1139 20161215 |
| 1392714 | 2017/019 | Ireland | ⤷ Start Trial | PRODUCT NAME: OBETICHOLIC ACID; REGISTRATION NO/DATE: EU/1/16/1139/001 EU/1/16/1139/002 20161212 |
| 2771003 | 21/2023 | Austria | ⤷ Start Trial | PRODUCT NAME: MARALIXIBAT ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, INSBESONDERE MARALIXIBATCHLORID; REGISTRATION NO/DATE: EU/1/22/1704 (MITTEILUNG) 20221212 |
| 1392714 | 1790020-0 | Sweden | ⤷ Start Trial | PRODUCT NAME: OBETICHOLIC ACID; REG. NO/DATE: EU/1/16/1139 20161215 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
